Using data from both The Cancer Genome Atlas (TCGA) and patient-derived samples, four independent groups reported downregulation of CLDN5 in CRC compared to normal colon samples [36,39,42,43]. The gene discussed is CLDN5; the disease is colorectal carcinoma.